Francois Nader insider trades

Open-market stock purchases and sales by Francois Nader, Director at Moderna, Inc, from SEC Form 4 filings since Oct 17, 2009.

Recent trades

DateStockTradeValue
May 6, 2026MRNA Moderna, IncBought (not open market)—
May 6, 2026MRNA Moderna, IncBought (not open market)—
Apr 30, 2026MRNA Moderna, IncBought (not open market)—
Apr 1, 2026TECX Tectonic Therapeutic, IncBought (not open market)—

Companies traded

  • MRNA Moderna, Inc: 1 sale, last May 6, 2026
  • TECX Tectonic Therapeutic, Inc: other filings, last Apr 1, 2026
  • TALS Talaris Therapeutics, Inc: 6 buys, last Jun 13, 2023
  • XLRN Acceleron Pharma Inc: other filings, last Nov 19, 2021
  • ALXN Alexion Pharmaceuticals, Inc: other filings, last Jul 21, 2021
  • PRVL Prevail Therapeutics Inc: other filings, last Jan 22, 2021
  • BXLT Baxalta Inc: other filings, last Jun 3, 2016
  • TRVN Trevena Inc: other filings, last May 20, 2015
  • NPSP NPS Pharmaceuticals Inc: 1 buy, 7 sales, last Feb 21, 2015
  • NSPS NPS Pharmaceuticals Inc: other filings, last Feb 17, 2011

Get free alerts when Francois Nader files a new trade →